Decade Capital Management’s Abiomed Inc ABMD Stock Holding History

Decade Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-35,310	Closed	-$2.53M	–	181
2015 Q1	$2.53M	Sell	35,310 -205,221	-85%	-$11.1M	0.31%	83
2014 Q4	$9.15M	Sell	240,531 -193,702	-45%	-$6.11M	1.57%	19
2014 Q3	$10.8M	Sell	434,233 -25,586	-6%	-$648K	1.26%	24
2014 Q2	$11.6M	Buy	+459,819	New	+$10.7M	1.15%	32

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Decade Capital Management's ABMD Position: Q2 2015 in Review

Decade Capital Management sold out of Abiomed Inc (ABMD) in Q2 2015, closing a stake of 35,310 shares — an estimated $2.53M sold.

Decade Capital Management first reported a position in ABMD in Q2 2014 and held it in 4 quarters. The position peaked at $11.6M in Q2 2014. 227 funds tracked by Wall St. Rank hold ABMD as of Q2 2015.

Decade Capital Management reported no remaining Abiomed Inc position as of Q2 2015 after selling out during the quarter.
Decade Capital Management sold 35,310 Abiomed Inc shares in Q2 2015, an estimated $2.53M.
Decade Capital Management first reported a position in Abiomed Inc in Q2 2014 and held it in 4 quarters.
Decade Capital Management's Abiomed Inc position peaked at $11.6M in Q2 2014.
227 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2015.

Based on Decade Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.